Vanhuyse M - Search Results

1

Impact of the introduction of novel hormonal agents on metastatic castration-resistant prostate cancer treatment choice.

Lahcene H, Aprikian AG, Vanhuyse M, Hu J, Bladou F, Cury F, Kassouf W, Perreault S, Dragomir A. Lahcene H, et al. Among authors: vanhuyse m. J Oncol Pharm Pract. 2020 Mar;26(2):293-305. doi: 10.1177/1078155219842329. Epub 2019 Apr 18. J Oncol Pharm Pract. 2020. PMID: 30997868

2

Drug costs in the management of metastatic castration-resistant prostate cancer in Canada.

Dragomir A, Dinea D, Vanhuyse M, Cury FL, Aprikian AG. Dragomir A, et al. Among authors: vanhuyse m. BMC Health Serv Res. 2014 Jun 13;14:252. doi: 10.1186/1472-6963-14-252. BMC Health Serv Res. 2014. PMID: 24927758 Free PMC article.

3

Impact of abiraterone acetate with and without prior docetaxel chemotherapy on the survival of patients with metastatic castration-resistant prostate cancer: a population-based study.

Rocha J, Aprikian AG, Vanhuyse M, Cury FL, Hu J, Prévost N, Dragomir A. Rocha J, et al. Among authors: vanhuyse m. CMAJ Open. 2017 Mar 28;5(1):E265-E272. doi: 10.9778/cmajo.20160082. eCollection 2017 Jan-Mar. CMAJ Open. 2017. PMID: 28401143 Free PMC article.

4

Phase I Clinical Trial of Everolimus Combined with Trimodality Therapy in Patients with Muscle-Invasive Bladder Cancer.

Bachir BG, Souhami L, Mansure JJ, Cury F, Vanhuyse M, Brimo F, Aprikian AG, Tanguay S, Sturgeon J, Kassouf W. Bachir BG, et al. Among authors: vanhuyse m. Bladder Cancer. 2017 Apr 27;3(2):105-112. doi: 10.3233/BLC-160090. Bladder Cancer. 2017. PMID: 28516155 Free PMC article.

5

Randomized, Noncomparative, Phase II Trial of Early Switch From Docetaxel to Cabazitaxel or Vice Versa, With Integrated Biomarker Analysis, in Men With Chemotherapy-Naïve, Metastatic, Castration-Resistant Prostate Cancer.

Antonarakis ES, Tagawa ST, Galletti G, Worroll D, Ballman K, Vanhuyse M, Sonpavde G, North S, Albany C, Tsao CK, Stewart J, Zaher A, Szatrowski T, Zhou W, Gjyrezi A, Tasaki S, Portella L, Bai Y, Lannin TB, Suri S, Gruber CN, Pratt ED, Kirby BJ, Eisenberger MA, Nanus DM, Saad F, Giannakakou P; TAXYNERGY Investigators. Antonarakis ES, et al. Among authors: vanhuyse m. J Clin Oncol. 2017 Oct 1;35(28):3181-3188. doi: 10.1200/JCO.2017.72.4138. Epub 2017 Jun 20. J Clin Oncol. 2017. PMID: 28632486 Free PMC article. Clinical Trial.

6

Development and Implementation of a Continuing Medical Education Program in Canada: Knowledge Translation for Renal Cell Carcinoma (KT4RCC).

Lavallée LT, Fitzpatrick R, Wood LA, Basiuk J, Knee C, Cnossen S, Mallick R, Witiuk K, Vanhuyse M, Tanguay S, Finelli A, Jewett MAS, Basappa N, Lattouf JB, Gotto GT, Al-Asaaed S, Bjarnason GA, Moore R, North S, Canil C, Pouliot F, Soulières D, Castonguay V, Kassouf W, Cagiannos I, Morash C, Breau RH. Lavallée LT, et al. Among authors: vanhuyse m. J Cancer Educ. 2019 Feb;34(1):14-18. doi: 10.1007/s13187-017-1259-7. J Cancer Educ. 2019. PMID: 28779441

7

Treatment patterns and trends in patients dying of prostate cancer in Quebec: a population-based study.

Dragomir A, Rocha J, Vanhuyse M, Cury FL, Kassouf W, Hu J, Aprikian AG. Dragomir A, et al. Among authors: vanhuyse m. Curr Oncol. 2017 Aug;24(4):240-248. doi: 10.3747/co.24.3598. Epub 2017 Aug 31. Curr Oncol. 2017. PMID: 28874892 Free PMC article.

8

Comparison of Surgery and Radiation as Local Treatments in the Risk of Locoregional Complications in Men Subsequently Dying From Prostate Cancer.

Hu J, Aprikian AG, Cury FL, Vanhuyse M, Zakaria AS, Richard PO, Perreault S, Dragomir A. Hu J, et al. Among authors: vanhuyse m. Clin Genitourin Cancer. 2017 Sep 5:S1558-7673(17)30266-5. doi: 10.1016/j.clgc.2017.08.011. Online ahead of print. Clin Genitourin Cancer. 2017. PMID: 28943330

9

Evaluation of New Tests and Interventions for Prostate Cancer Management: A Systematic Review.

Olleik G, Kassouf W, Aprikian A, Hu J, Vanhuyse M, Cury F, Peacock S, Bonnevier E, Palenius E, Dragomir A. Olleik G, et al. Among authors: vanhuyse m. J Natl Compr Canc Netw. 2018 Nov;16(11):1340-1351. doi: 10.6004/jnccn.2018.7055. J Natl Compr Canc Netw. 2018. PMID: 30442734

10

Cancer Drug Use in the Last Month of Life in Men With Castration-Resistant Prostate Cancer.

Hu J, Aprikian AG, Vanhuyse M, Dragomir A. Hu J, et al. Among authors: vanhuyse m. J Oncol Pract. 2019 Jun;15(6):e510-e519. doi: 10.1200/JOP.18.00626. Epub 2019 May 20. J Oncol Pract. 2019. PMID: 31107628

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters